Enforcement of the U.S. Food, Drug and Cosmetic Act will be the focus of an upcoming program on Widener Law’s Delaware campus.
[ Brochure and Registration PDF
The event, presented by Widener’s student Food and Drug Law Association
in partnership with the Washington, D.C.-based Food and Drug Law Institute will bring together government officials with industry and academic experts to address legal and regulatory matters related to civil and criminal enforcement of the Act. The program will also examine ethical and accountability issues, and professional conduct standards.
The conference will run 3:30 to 5:30 p.m. on Tuesday, March 1 in the Ruby R. Vale Moot Courtroom on Widener’s campus at 4601 Concord Pike, Wilmington, Del. Check-in begins at 3 p.m. and a reception will follow the event.
- Karyn M. Campbell, the FDA director of investigations, Philadelphia office.
- Theresa P. DeLaine, senior medical sales specialist with Eisai, Inc.
- John Pease, assistant U.S. attorney and chief of government and health care fraud for the Eastern District of Pennsylvania.
- Roseann B. Termini, Widener Law adjunct professor of food and drug law.
Attorneys from Delaware and Pennsylvania who attend the program will be eligible for two continuing legal education credits, including one ethics credit. The registration fee for attorneys who attend for credit is $50, or $25 for government, academic and nonlegal professional association members. Attendance is free for students or members of the public not seeking continuing legal education credits.
To register, contact Constance Sweeney at 302.477.2177 or email@example.com